Figure 8 Implanted devices for the management of heart failure

Slides:

Advertisements

Similar presentations

Figure 1 Venomous snakes

Advertisements

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;

Figure 1 Incidence and mortality of cutaneous melanoma

Figure 2 Electromechanical properties of OIHPs

Figure 6 Selected examples of TERS applications in material systems

Figure 1 Anatomy of the spinal column

Nat. Rev. Cardiol. doi: /nrcardio

Reproduced with permission from Yancy, C. W. et al. 2017

Figure 5 BMI and cardiorespiratory fitness levels

Figure 4 BMI and mortality in patients with heart failure

Figure 1 Energy supply–demand matching in health and heart failure

Figure 2 Pathological specimens showing the most common reasons for bioprosthetic valve failure Figure 2 | Pathological specimens showing the most common.

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Bad-metal behaviour and electron correlations

Figure 1 Anatomy of the femoral artery

Figure 7 European Society of Cardiology 2016

Figure 4 Effects of delaying cardioprotective medications after anthracycline administration Figure 4 | Effects of delaying cardioprotective medications.

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Prevalence of HFpEF and HFrEF by age

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 6 Imaging methods used to study Parkinson disease

Palliative Care and Hospice Programs

Figure 1 Cardiovascular risk and disease across the life-course

Figure 1 Decision tree integrating the assessment,

Figure 2 Incidence of multiple myeloma in 2012

Figure 1 Clinical correlates of neurodegeneration in MS

Figure 2 Global cost of HF per capita in 2012

Figure 2 A patient with aortic stenosis and mitral regurgitation

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Cardiol. doi: /nrcardio

Run chart showing outcomes of interventions expressed as percentage of cases with active implantable cardioverter defibrillator (ICD) in situ postmortem. PDSA, Plan-Do-Study-Act.

Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.

Figure 3 Challenges for big data applications in cardiovascular care

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 8 HRQOL in individuals with RA

Medical management of osteoarthritis

Prabhat Kumar et al. JACEP 2016;j.jacep

Figure 4 Diagnosing neuropathic pain

MicroRNAs in Memory Processing

Figure 1 Structure of ADAMTS13

Figure 2 Dzyaloshinskii–Moriya interactions

Shannon M. Dunlay, MD, MS, Naveen L. Pereira, MD, Sudhir S

Adapted with permission from Tesfaye, S. , Boulton, A. J

Figure 9 Management of atrial fibrillation

Figure 3.3. Change in average annual runoff by the 2050s under the SRES A2 emissions scenario and different climate models (Arnell,

Figure 2 Impaired mitochondrial capacity and function in heart failure

Figure 2 Global mortality and incidence rates of pancreatic cancer

Nat. Rev. Cardiol. doi: /nrcardio

Figure 7 Prototypes of topological mechanical metamaterials

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Rett syndrome severity and age at diagnosis by mutation type

Figure 2 Global kidney cancer incidence

Figure 4 4D printing schemes and time-evolving structure geometries

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Treponema pallidum invasion

Results of comparisons of treatments in the network.

Figure 5 Algorithm for the management of hypertension

Figure 2 Diffusio-osmotic process for osmotic energy conversion

Acute and Chronic Seizures in Patients Older Than 60 Years

Nat. Rev. Mater. doi: /natrevmats

Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.

Figure 4 Clinical manifestations of alopecia areata

Part b is reproduced with permission from Messenger, A. G

Nat. Rev. Mater. doi: /natrevmats

Comparison of heart failure admissions rates per annum (recorded hospital admissions/ population at risk) in western developed countries 1978 to.

Survival free of atrial fibrillation after implantation of an implantable cardioverter defibrillator in our series (151 patients): overall population (solid.

Presentation transcript:

Figure 8 Implanted devices for the management of heart failure Part a adapted with permission from Lewis, G. F. & Gold, M. R. Clinical experience with subcutaneous implantable cardioverter-defibrillators. Nat. Rev. Cardiol. 12, 398–405 (2015), Macmillan Publishers Ltd. Part b used by permission of Mayo Foundation for Medical Education and Research. All rights reserved. Part c and part d adapted with permission from Abraham, W. T. & Smith, S. A. Devices in the management of advanced, chronic heart failure. Nat. Rev. Cardiol. 10, 98–110 (2013), Macmillan Publishers Ltd Bloom, M. W. et al. (2017) Heart failure with reduced ejection fraction Nat. Rev. Dis. Primers doi:10.1038/nrdp.2017.58